Safety of thrombolytic therapy in normally menstruating women with acute myocardial infarction.
Lanter
P L
PL
Department of Medicine, Medical College of Virginia/Virginia Commonwealth University, Richmond 23298-0105.
Jennings
C F
CF
Roberts
C S
CS
Jesse
R L
RL
D000328:Adult; D005260:Female; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D008598:Menstruation / Q000097:blood / Q000187:drug effects*; D008875:Middle Aged; D009203:Myocardial Infarction / Q000097:blood / Q000188:drug therapy*; D012189:Retrospective Studies; D012307:Risk Factors; D012449:Safety; D013300:Streptokinase / Q000008:administration & dosage / Q000627:therapeutic use*; D015912:Thrombolytic Therapy; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage / Q000627:therapeutic use*
D006454:Hemoglobins; D013300:Streptokinase; D010959:Tissue Plasminogen Activator